acetylsalicylic acid is one of 432 small molecule programs targeting Colorectal Cancer. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
350 competitors in Treatment
acetylsalicylic acid
Biltricide
Dexilant
Alfenta
Minipress
Niclocide
Hivid
Foscavir
Lotemax
Barhemsys
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources